Effect of Healing Touch on the Experience of Women Undergoing Treatment for Breast Cancer

This study is ongoing, but not recruiting participants.

First Received: September 20, 2007 Last Updated: December 11, 2008 History of Changes

Sponsors and Collaborators:	Stanford University Avon Foundation
Information provided by:	Stanford University
ClinicalTrials.gov Identifier:	NCT00533780

Purpose

To learn what effect, if any, Healing Touch (a gentle, non-invasive form of energy work that promotes relaxation and can help manage the side effects of chemotherapy and radiation), has on physical symptoms, mood, and qualify of life for women undergoing treatment for breast cancer.

Condition	Intervention
Breast Cancer	Procedure: Healing Touch

Genetics Home Reference related topics: breast cancer

MedlinePlus related topics: Breast Cancer Cancer

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Non-Randomized, Open Label, Active Control, Single Group Assignment, Efficacy Study
Official Title:	Effect of Healing Touch on the Experience of Women Undergoing Treatment for Breast Cancer

Further study details as provided by Stanford University:

Primary Outcome Measures:

Measure: Effect HT has on physical symptoms, mood and quality of life for women undergoing treatment for breast cancer.

Estimated Enrollment:	200
Study Start Date:	January 2005

Eligibility

Ages Eligible for Study:	18 Years to 70 Years
Genders Eligible for Study:	Female
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:- Patients undergoing treatment for breast cancer.

Age 18 or over.
Participants in Healing Partners Program.
 Exclusion Criteria:- Patients not under the care of a physician.
Patients not able to come to regular healing touch sessions.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00533780

Locations

United States, California
Stanford University School of Medicine
Stanford, California, United States, 94305

Sponsors and Collaborators

Stanford University

Avon Foundation

Investigators

Principal Investigator:

Lynn m Westphal

Stanford University

More Information

No publications provided

Study ID Numbers:	BRSADJ0003, 95738, BRSADJ0003, NCT00533780
Study First Received:	September 20, 2007
Last Updated:	December 11, 2008
ClinicalTrials.gov Identifier:	NCT00533780 History of Changes
Health Authority:	United States: Food and Drug Administration; United States: Institutional Review Board

Study placed in the following topic categories:

Skin Diseases
Breast Neoplasms
Breast Diseases

Additional relevant MeSH terms:

Neoplasms
Neoplasms by Site
Skin Diseases
Breast Neoplasms
Breast Diseases

ClinicalTrials.gov processed this record on May 07, 2009